Product Description
Matrixk Biotek SHIKARI® S-ATB (Quantitative)
Enzyme immunoassay for the quantitative determination of antibodies to Bevacizumab (Avastin) in serum and plasma samples.
Specifications:
| Required Volume (µl) | 20 |
| Total Time (min) | 140 |
| Sample | Serum, Plasma |
| Sample Number | 96 |
| Detection Limit (ng/mL) | 15 |
| Spike Recovery (%) | Between 85-115 |
| Shelf Life (year) | 1 |
Documentation
Download IFU (Quantitative)
Download MSDS (Quantitative)
Please note that the documentation provided is for reference use only. For the most updated version, please contact us.
For Research Use Only
Manufactured by Matriks Biotek Co.
*AVASTIN® IS A REGISTERED TRADEMARK OF GENENTECH, INC.
| Questions about this product? Ready to place an order? Email us at orders@iwai-chem.com or give us a call: (650) 486-1541 |
